These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32488364)

  • 1. [ANCA diagnostics in vasculitis].
    Csernok E; Hellmich B
    Z Rheumatol; 2020 Sep; 79(7):669-678. PubMed ID: 32488364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies.
    Bossuyt X; Rasmussen N; van Paassen P; Hellmich B; Baslund B; Vermeersch P; Blockmans D; Cohen Tervaert JW; Csernok E; Damoiseaux J
    Rheumatology (Oxford); 2017 Sep; 56(9):1533-1541. PubMed ID: 28541581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays.
    Damoiseaux J; Csernok E; Rasmussen N; Moosig F; van Paassen P; Baslund B; Vermeersch P; Blockmans D; Cohen Tervaert JW; Bossuyt X
    Ann Rheum Dis; 2017 Apr; 76(4):647-653. PubMed ID: 27481830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
    Kim SM; Choi SY; Kim SY; Kim J
    Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-neutrophil cytoplasm antibodies (ANCA): Recent methodological advances-Lead to new consensus recommendations for ANCA detection.
    Csernok E; Mahrhold J; Hellmich B
    J Immunol Methods; 2018 May; 456():1-6. PubMed ID: 29395165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ANCA-associated vasculitis: recent methodological advances for ANCA detection].
    Csernok E
    Dtsch Med Wochenschr; 2018 Apr; 143(7):499-502. PubMed ID: 29614541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis.
    Guchelaar NAD; Waling MM; Adhin AA; van Daele PLA; Schreurs MWJ; Rombach SM
    Autoimmun Rev; 2021 Jan; 20(1):102716. PubMed ID: 33197574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis.
    Walker BS; Peterson LK; Koening C; White SK; Schmidt RL; Tebo AE
    Autoimmun Rev; 2022 Jun; 21(6):103100. PubMed ID: 35452854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis.
    Bornstein G; Ben-Zvi I; Furie N; Grossman C
    Int J Rheum Dis; 2019 May; 22(5):940-945. PubMed ID: 30729688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease.
    Savige J; Trevisin M; Pollock W
    J Immunol Methods; 2018 Jul; 458():1-7. PubMed ID: 29486145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing.
    Rao DA; Wei K; Merola JF; O'Brien WR; Takvorian SU; Dellaripa PF; Schur PH
    J Rheumatol; 2015 May; 42(5):847-52. PubMed ID: 25834211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
    Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Laboratory diagnostics of ANCA-vasculitis].
    Salamunić I; Kaliterna DM
    Reumatizam; 2013; 60(2):39-42. PubMed ID: 24979995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Paradigm shift in ANCA diagnostics : New international consensus recommendations].
    Csernok E; Kempiners N; Hellmich B
    Z Rheumatol; 2017 Mar; 76(2):143-148. PubMed ID: 28058500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
    Csernok E; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.
    Hilhorst M; van Paassen P; Tervaert JW;
    J Am Soc Nephrol; 2015 Oct; 26(10):2314-27. PubMed ID: 25956510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
    Mohammad AJ; Segelmark M
    J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinase-3 antineutrophil cytoplasm antibody positivity in patients without primary systemic vasculitis.
    McAdoo SP; Hall A; Levy J; Salama AD; Pusey CD
    J Clin Rheumatol; 2012 Oct; 18(7):336-40. PubMed ID: 23047533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of PR3- and MPO-ANCA line and dot immunoassays in ANCA-associated vasculitis.
    Kempiners N; Mahrhold J; Hellmich B; Csernok E
    Rheumatology (Oxford); 2021 Sep; 60(9):4390-4394. PubMed ID: 33316047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.